Perfil
Joshua Rosenblat is the founder of 1907 Foundation.
He is currently working as an Assistant Professor at the University of Toronto, a Clinical & Technical Advisor at iGan Partners, and as the Chief Medical & Scientific Officer at Braxia Scientific Corp.
He completed his undergraduate degree at the University of Toronto and his doctorate at the University of Western Ontario.
Cargos activos de Joshua Rosenblat
| Empresas | Cargo | Inicio |
|---|---|---|
| CHAMPIGNON BRANDS | Director Técnico/Científico/I+D | 28/05/2021 |
iGan Partners
iGan Partners Investment ManagersFinance iGan Partners invests in companies located in Canada. The firm targets companies operating in the fields of healthcare technology, digital therapeutics, medical devices,AI- enabled MedTech and digital health sector. It provides financing for seed and early stage capital requirements. It also makes follow-on-investments. | Consultor / Asesor | - |
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
1907 Foundation | Fundador | - |
Formación de Joshua Rosenblat.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Western Ontario
University of Western Ontario Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
iGan Partners
iGan Partners Investment ManagersFinance iGan Partners invests in companies located in Canada. The firm targets companies operating in the fields of healthcare technology, digital therapeutics, medical devices,AI- enabled MedTech and digital health sector. It provides financing for seed and early stage capital requirements. It also makes follow-on-investments. | Finance |
Braxia Scientific Corp.
Braxia Scientific Corp. BiotechnologyHealth Technology Develops ketamine treatment and psychedelic medicine for mental health treatments | Health Technology |
1907 Foundation |
- Bolsa de valores
- Insiders
- Joshua Rosenblat
















